APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Raw Material Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Raw Material Testing Service Market Analysis and Forecast 2026-2032

17 January 2026194 pages

Choose your research edition.

Industry ResearchPharmaceutical Raw Material Testing Service Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Raw Material Testing Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Raw Material Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Raw Material Testing Service Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Raw Material Testing Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharmaceutical Raw Material Testing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Raw Material Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Raw Material Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Raw Material Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Raw Material Testing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Raw Material Testing Service include ARBRO, Boston Analytical, CPT Labs, Element, Eurofins Scientific, Intertek, Nelson Labs, Pace Analytical and SGS Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Raw Material Testing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Raw Material Testing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Raw Material Testing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Raw Material Testing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Raw Material Testing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Raw Material Testing Service revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Raw Material Testing Service Segment by Company

ARBRO

Boston Analytical

CPT Labs

Element

Eurofins Scientific

Intertek

Nelson Labs

Pace Analytical

SGS Group

Tepnel

TÜV SUD

Pharmaceutical Raw Material Testing Service Segment by Type

Pharmaceutical Substances

Intermediates

Excipients

Other

Pharmaceutical Raw Material Testing Service Segment by Application

Pharmaceutical

Bio-pharmacy

Other

Pharmaceutical Raw Material Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Raw Material Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Raw Material Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Raw Material Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Raw Material Testing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Raw Material Testing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Raw Material Testing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Raw Material Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmaceutical Substances Major Player Table 3. Intermediates Major Player Table 4. Excipients Major Player Table 5. Other Major Player Table 6. Global Pharmaceutical Raw Material Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Major Player Table 8. Bio-pharmacy Major Player Table 9. Other Major Player Table 10. Pharmaceutical Raw Material Testing Service Industry Trends Table 11. Pharmaceutical Raw Material Testing Service Industry Drivers Table 12. Pharmaceutical Raw Material Testing Service Industry Opportunities and Challenges Table 13. Pharmaceutical Raw Material Testing Service Industry Restraints Table 14. Global Pharmaceutical Raw Material Testing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Pharmaceutical Raw Material Testing Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Pharmaceutical Raw Material Testing Service Market Share by Region (2021-2026) Table 17. Global Pharmaceutical Raw Material Testing Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Pharmaceutical Raw Material Testing Service Market Share by Region (2027-2032) Table 19. Global Pharmaceutical Raw Material Testing Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Players (2021-2026) Table 21. Global Pharmaceutical Raw Material Testing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Pharmaceutical Raw Material Testing Service Key Players Headquarters & Area Served Table 23. Global Pharmaceutical Raw Material Testing Service Players, Product Type & Application Table 24. Global Pharmaceutical Raw Material Testing Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Pharmaceutical Raw Material Testing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Pharmaceutical Raw Material Testing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Type (2021-2026) Table 31. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Type (2027-2032) Table 32. Global Pharmaceutical Raw Material Testing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Application (2021-2026) Table 36. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Application (2027-2032) Table 37. ARBRO Company Information Table 38. ARBRO Business Overview Table 39. ARBRO Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. ARBRO Pharmaceutical Raw Material Testing Service Product Portfolio Table 41. ARBRO Recent Development Table 42. Boston Analytical Company Information Table 43. Boston Analytical Business Overview Table 44. Boston Analytical Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Boston Analytical Pharmaceutical Raw Material Testing Service Product Portfolio Table 46. Boston Analytical Recent Development Table 47. CPT Labs Company Information Table 48. CPT Labs Business Overview Table 49. CPT Labs Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. CPT Labs Pharmaceutical Raw Material Testing Service Product Portfolio Table 51. CPT Labs Recent Development Table 52. Element Company Information Table 53. Element Business Overview Table 54. Element Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Element Pharmaceutical Raw Material Testing Service Product Portfolio Table 56. Element Recent Development Table 57. Eurofins Scientific Company Information Table 58. Eurofins Scientific Business Overview Table 59. Eurofins Scientific Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Eurofins Scientific Pharmaceutical Raw Material Testing Service Product Portfolio Table 61. Eurofins Scientific Recent Development Table 62. Intertek Company Information Table 63. Intertek Business Overview Table 64. Intertek Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Intertek Pharmaceutical Raw Material Testing Service Product Portfolio Table 66. Intertek Recent Development Table 67. Nelson Labs Company Information Table 68. Nelson Labs Business Overview Table 69. Nelson Labs Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Nelson Labs Pharmaceutical Raw Material Testing Service Product Portfolio Table 71. Nelson Labs Recent Development Table 72. Pace Analytical Company Information Table 73. Pace Analytical Business Overview Table 74. Pace Analytical Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Pace Analytical Pharmaceutical Raw Material Testing Service Product Portfolio Table 76. Pace Analytical Recent Development Table 77. SGS Group Company Information Table 78. SGS Group Business Overview Table 79. SGS Group Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. SGS Group Pharmaceutical Raw Material Testing Service Product Portfolio Table 81. SGS Group Recent Development Table 82. Tepnel Company Information Table 83. Tepnel Business Overview Table 84. Tepnel Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Tepnel Pharmaceutical Raw Material Testing Service Product Portfolio Table 86. Tepnel Recent Development Table 87. TÜV SUD Company Information Table 88. TÜV SUD Business Overview Table 89. TÜV SUD Pharmaceutical Raw Material Testing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. TÜV SUD Pharmaceutical Raw Material Testing Service Product Portfolio Table 91. TÜV SUD Recent Development Table 92. North America Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Pharmaceutical Raw Material Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Pharmaceutical Raw Material Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 98. North America Pharmaceutical Raw Material Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Pharmaceutical Raw Material Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Pharmaceutical Raw Material Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe Pharmaceutical Raw Material Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 106. China Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 107. China Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 108. China Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 109. China Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Pharmaceutical Raw Material Testing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Pharmaceutical Raw Material Testing Service Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia Pharmaceutical Raw Material Testing Service Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA Pharmaceutical Raw Material Testing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA Pharmaceutical Raw Material Testing Service Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA Pharmaceutical Raw Material Testing Service Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Pharmaceutical Raw Material Testing Service Image Figure 2. Global Pharmaceutical Raw Material Testing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Raw Material Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmaceutical Substances Image Figure 5. Intermediates Image Figure 6. Excipients Image Figure 7. Other Image Figure 8. Global Pharmaceutical Raw Material Testing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pharmaceutical Raw Material Testing Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Image Figure 11. Bio-pharmacy Image Figure 12. Other Image Figure 13. Global Pharmaceutical Raw Material Testing Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Pharmaceutical Raw Material Testing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Raw Material Testing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Raw Material Testing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Pharmaceutical Raw Material Testing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Pharmaceutical Raw Material Testing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Type (2021-2032) Figure 21. Global Pharmaceutical Raw Material Testing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Application (2021-2032) Figure 24. North America Pharmaceutical Raw Material Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032) Figure 26. North America Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032) Figure 27. North America Pharmaceutical Raw Material Testing Service Revenue Share by Country (2021-2032) Figure 28. United States Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Pharmaceutical Raw Material Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032) Figure 33. Europe Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032) Figure 34. Europe Pharmaceutical Raw Material Testing Service Revenue Share by Country (2021-2032) Figure 35. Germany Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Pharmaceutical Raw Material Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032) Figure 45. China Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032) Figure 46. Asia Pharmaceutical Raw Material Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032) Figure 48. Asia Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032) Figure 49. Asia Pharmaceutical Raw Material Testing Service Revenue Share by Region (2021-2032) Figure 50. Japan Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Pharmaceutical Raw Material Testing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Pharmaceutical Raw Material Testing Service Revenue Share by Country (2021-2032) Figure 60. Brazil Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Pharmaceutical Raw Material Testing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Substances
  • Intermediates
  • Excipients
  • Other
Applications
  • Pharmaceutical
  • Bio-pharmacy
  • Other
Companies covered
  • ARBRO
  • Boston Analytical
  • CPT Labs
  • Element
  • Eurofins Scientific
  • Intertek
  • Nelson Labs
  • Pace Analytical
  • SGS Group
  • Tepnel
  • TÜV SUD

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Raw Material Testing Service Market by Type
  3. 1.2.1 Global Pharmaceutical Raw Material Testing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmaceutical Substances
  5. 1.2.3 Intermediates
  6. 1.2.4 Excipients
  7. 1.2.5 Other
  8. 1.3 Pharmaceutical Raw Material Testing Service Market by Application
  9. 1.3.1 Global Pharmaceutical Raw Material Testing Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical
  11. 1.3.3 Bio-pharmacy
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Pharmaceutical Raw Material Testing Service Market Dynamics
  1. 2.1 Pharmaceutical Raw Material Testing Service Industry Trends
  2. 2.2 Pharmaceutical Raw Material Testing Service Industry Drivers
  3. 2.3 Pharmaceutical Raw Material Testing Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Raw Material Testing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Raw Material Testing Service Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Raw Material Testing Service Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Raw Material Testing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Raw Material Testing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Raw Material Testing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Raw Material Testing Service Revenue by Players
  2. 4.1.1 Global Pharmaceutical Raw Material Testing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Raw Material Testing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Raw Material Testing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Raw Material Testing Service Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Raw Material Testing Service Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Raw Material Testing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Raw Material Testing Service Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Raw Material Testing Service Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Raw Material Testing Service Market Size by Type
  1. 5.1 Global Pharmaceutical Raw Material Testing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Raw Material Testing Service Market Size by Application
  1. 6.1 Global Pharmaceutical Raw Material Testing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Raw Material Testing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ARBRO
  2. 7.1.1 ARBRO Company Information
  3. 7.1.2 ARBRO Business Overview
  4. 7.1.3 ARBRO Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ARBRO Pharmaceutical Raw Material Testing Service Product Portfolio
  6. 7.1.5 ARBRO Recent Developments
  7. 7.2 Boston Analytical
  8. 7.2.1 Boston Analytical Company Information
  9. 7.2.2 Boston Analytical Business Overview
  10. 7.2.3 Boston Analytical Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boston Analytical Pharmaceutical Raw Material Testing Service Product Portfolio
  12. 7.2.5 Boston Analytical Recent Developments
  13. 7.3 CPT Labs
  14. 7.3.1 CPT Labs Company Information
  15. 7.3.2 CPT Labs Business Overview
  16. 7.3.3 CPT Labs Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CPT Labs Pharmaceutical Raw Material Testing Service Product Portfolio
  18. 7.3.5 CPT Labs Recent Developments
  19. 7.4 Element
  20. 7.4.1 Element Company Information
  21. 7.4.2 Element Business Overview
  22. 7.4.3 Element Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Element Pharmaceutical Raw Material Testing Service Product Portfolio
  24. 7.4.5 Element Recent Developments
  25. 7.5 Eurofins Scientific
  26. 7.5.1 Eurofins Scientific Company Information
  27. 7.5.2 Eurofins Scientific Business Overview
  28. 7.5.3 Eurofins Scientific Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Scientific Pharmaceutical Raw Material Testing Service Product Portfolio
  30. 7.5.5 Eurofins Scientific Recent Developments
  31. 7.6 Intertek
  32. 7.6.1 Intertek Company Information
  33. 7.6.2 Intertek Business Overview
  34. 7.6.3 Intertek Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Intertek Pharmaceutical Raw Material Testing Service Product Portfolio
  36. 7.6.5 Intertek Recent Developments
  37. 7.7 Nelson Labs
  38. 7.7.1 Nelson Labs Company Information
  39. 7.7.2 Nelson Labs Business Overview
  40. 7.7.3 Nelson Labs Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nelson Labs Pharmaceutical Raw Material Testing Service Product Portfolio
  42. 7.7.5 Nelson Labs Recent Developments
  43. 7.8 Pace Analytical
  44. 7.8.1 Pace Analytical Company Information
  45. 7.8.2 Pace Analytical Business Overview
  46. 7.8.3 Pace Analytical Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Pace Analytical Pharmaceutical Raw Material Testing Service Product Portfolio
  48. 7.8.5 Pace Analytical Recent Developments
  49. 7.9 SGS Group
  50. 7.9.1 SGS Group Company Information
  51. 7.9.2 SGS Group Business Overview
  52. 7.9.3 SGS Group Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 SGS Group Pharmaceutical Raw Material Testing Service Product Portfolio
  54. 7.9.5 SGS Group Recent Developments
  55. 7.10 Tepnel
  56. 7.10.1 Tepnel Company Information
  57. 7.10.2 Tepnel Business Overview
  58. 7.10.3 Tepnel Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Tepnel Pharmaceutical Raw Material Testing Service Product Portfolio
  60. 7.10.5 Tepnel Recent Developments
  61. 7.11 TÜV SUD
  62. 7.11.1 TÜV SUD Company Information
  63. 7.11.2 TÜV SUD Business Overview
  64. 7.11.3 TÜV SUD Pharmaceutical Raw Material Testing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 TÜV SUD Pharmaceutical Raw Material Testing Service Product Portfolio
  66. 7.11.5 TÜV SUD Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Raw Material Testing Service Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Raw Material Testing Service Revenue by Country
  11. 8.6.1 North America Pharmaceutical Raw Material Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Raw Material Testing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Raw Material Testing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Raw Material Testing Service Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Raw Material Testing Service Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Raw Material Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Raw Material Testing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Raw Material Testing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Raw Material Testing Service Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Raw Material Testing Service Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Raw Material Testing Service Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Raw Material Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Raw Material Testing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Raw Material Testing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Raw Material Testing Service Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Raw Material Testing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Raw Material Testing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Raw Material Testing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst